General InformationDechra Pharmaceuticals is a publicly-listed veterinary pharmaceutical company headquartered in Northwich, England, with over 1,000 employees, founded in 1997.
Funding & FinancialsAs a public company listed on the London Stock Exchange (AIM), Dechra has raised capital through public markets rather than traditional venture funding rounds.
Leadership & TeamDechra is led by CEO Gonzalo Vizcay, who joined in 2019 and has driven the company's growth through strategic acquisitions and market expansion.
Recent ActivityDechra has expanded its product portfolio through acquisitions and launched several new veterinary medications in companion animal dermatology and pain management segments in recent years.